A common culprit of skin and respiratory infections, Staphylococcus aureus is highly uncertain. Between 20 and 30 percent of people carry quiet colonies on their skin and in their nostrils, which seldom cause problems beyond the occasional rash. But in some cases these bacteria cause infections that lead to deadly …Read More »
Chromatography doesn’t want to be overwhelmed by the processing demands and cost pressures associated with next-generation medicines. Instead, chromatography is strengthening its commitment to innovation. The ability to meet new challenges is a highly refined trait in chromatography. Indeed, chromatography has been improving ever since it began separating pigments and …Read More »
Deveron UAS Corp. (CVE: DVR) a publicly traded company in Canada is growing a network of drones utilized for large scale agriculture data collection. The data is used for accuracy to increase crop yields and reduce farming application costs: The service process begins with one of Deveron’s drones equipped with …Read More »
Deveron UAS is a drone data services company specializing in agriculture. The company has completed over 500 commercial flights in 2016 and have solidified their first mover advantage by investing heavily in drones and pilots while growing their client base to include many industry leaders such as Bonduelle North America, …Read More »
The value of medical research implies both, the economic benefit, but also the improving of health, even when investing in small companies. When many people wonder what the real value of medical research is, they may believe that it is the millions of dollars that are earned by the drug …Read More »
Every day, research and development for orphan drugs are made to improve the health of thousands of people. Investors are needed for it. Recent data show that there are currently 138 thousand 691 medical research for drug development. The figures, published by the US National Institutes of Health, point out …Read More »
Medicine and health care have become an interesting binomial in which to invest, especially if you approach laboratories for rare diseases. Rare diseases affect more than 230 million people in the world, and the great majority of the great pharmacists little turn to see. Anyhow, some few laboratories work on …Read More »
Although it is considered that it has no cure, there are currently researches for a treatment of cystinuria, and investing in it could be a huge opportunity. Cystinuria is a rare congenital disease that causes the formation of kidney stones, and affects more than 12,000 people in the United States …Read More »
The future of medicine is in the investment of people seeking to expand their personal resources and make a good to the global population. Today, the population lives up to three decades more than 100 years ago, thanks to research and development of new medicines. The future of medicine is …Read More »
Clinical research companies need a lot of money to keep on their investigations; by investing on them, the profits go beyond the material. Every good investor’s secret is to have the capacity to understand the stock market. There are several things to know about purchasing or selling shares, and the …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!